{"id":"https://openalex.org/W7204512780","doi":null,"title":"Pharmacometric Modeling of Disease Progression and Biomarker Dynamics in Type 2 Diabetes","display_name":"Pharmacometric Modeling of Disease Progression and Biomarker Dynamics in Type 2 Diabetes","alternate_titles":[],"publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7204512780"},"language":"en","primary_location":{"id":"pmh:oai:DiVA.org:uu-594647","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-594647","pdf_url":null,"source":{"id":"https://openalex.org/S4306400653","display_name":"DiVA (Digitala Vetenskapliga Arkivet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},"parent_works":[],"lineage":["https://openalex.org/W7204512780"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-594647","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085967957","display_name":"Hanna Kunina","orcid":"https://orcid.org/0009-0000-0512-545X","observed_orcids":["https://orcid.org/0009-0000-0512-545X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kunina, Hanna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5085967957"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.45899999141693115,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.45899999141693115,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.382099986076355,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0731000006198883,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.8920000195503235},{"id":"https://openalex.org/keywords/antidiabetic-drug-development","display_name":"antidiabetic drug development","score":0.9190000295639038},{"id":"https://openalex.org/keywords/continuous-glucose-monitoring","display_name":"continuous glucose monitoring","score":0.9300000071525574},{"id":"https://openalex.org/keywords/glucose-insulin-dynamics","display_name":"glucose-insulin dynamics","score":0.8460000157356262},{"id":"https://openalex.org/keywords/multistate-models","display_name":"multi-state models","score":0.7879999876022339},{"id":"https://openalex.org/keywords/competing-risks","display_name":"competing risks","score":0.9769999980926514},{"id":"https://openalex.org/keywords/macrovascular-complications","display_name":"macrovascular complications","score":0.9359999895095825},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cardiometabolic-dysfunction","display_name":"cardiometabolic dysfunction","score":0.8960000276565552},{"id":"https://openalex.org/keywords/item-response-theory","display_name":"item response theory","score":0.9309999942779541},{"id":"https://openalex.org/keywords/biomarker-trajectories","display_name":"biomarker trajectories","score":0.5289999842643738},{"id":"https://openalex.org/keywords/informative-missingness","display_name":"informative missingness","score":0.9300000071525574},{"id":"https://openalex.org/keywords/trial-duration","display_name":"trial duration","score":0.3840000033378601},{"id":"https://openalex.org/keywords/long-term-clinical-outcomes","display_name":"long-term clinical outcomes","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8134999871253967},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7038999795913696},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6675000190734863},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4961000084877014},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.48660001158714294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47780001163482666},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4699000120162964},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.46869999170303345},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4634000062942505},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.43209999799728394},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4025999903678894},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39750000834465027},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.3864000141620636},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38280001282691956},{"id":"https://openalex.org/C2986379492","wikidata":"https://www.wikidata.org/wiki/Q1638492","display_name":"Continuous glucose monitoring","level":4,"score":0.3817000091075897},{"id":"https://openalex.org/C2778848681","wikidata":"https://www.wikidata.org/wiki/Q6725716","display_name":"Macrovascular disease","level":4,"score":0.3727000057697296},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.36809998750686646},{"id":"https://openalex.org/C124535831","wikidata":"https://www.wikidata.org/wiki/Q4915074","display_name":"Biomarker discovery","level":4,"score":0.358599990606308},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.352400004863739},{"id":"https://openalex.org/C119709500","wikidata":"https://www.wikidata.org/wiki/Q2142347","display_name":"Exposome","level":2,"score":0.3427000045776367},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.3237000107765198},{"id":"https://openalex.org/C2909914741","wikidata":"https://www.wikidata.org/wiki/Q256289","display_name":"Endpoint Determination","level":3,"score":0.3093999922275543},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2957000136375427},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.26840001344680786},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.26570001244544983},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26570001244544983},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.26510000228881836},{"id":"https://openalex.org/C2993043200","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical research","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.2630999982357025},{"id":"https://openalex.org/C45804977","wikidata":"https://www.wikidata.org/wiki/Q7239673","display_name":"Predictive modelling","level":2,"score":0.25679999589920044}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:DiVA.org:uu-594647","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-594647","pdf_url":null,"source":{"id":"https://openalex.org/S4306400653","display_name":"DiVA (Digitala Vetenskapliga Arkivet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"}],"best_oa_location":{"id":"pmh:oai:DiVA.org:uu-594647","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-594647","pdf_url":null,"source":{"id":"https://openalex.org/S4306400653","display_name":"DiVA (Digitala Vetenskapliga Arkivet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2617262801","https://openalex.org/W7203894635","https://openalex.org/W4214914836","https://openalex.org/W2778563215","https://openalex.org/W2275921633","https://openalex.org/W4414589580","https://openalex.org/W2014825234","https://openalex.org/W2563244719","https://openalex.org/W2084496283","https://openalex.org/W2092341553"],"abstract_inverted_index":{"In":[0,268,311],"antidiabetic":[1,87,321],"drug":[2,88,322],"development":[3,76,89,323],"for":[4,172,282],"type":[5],"2":[6],"diabetes":[7],"(T2D),":[8],"short-term":[9],"changes":[10],"in":[11,44,142,180,307],"glucose-related":[12],"biomarkers":[13,226,351],"need":[14],"to":[15,82,138,203],"be":[16,118],"translated":[17],"into":[18,229],"longer-term":[19],"treatment":[20],"response":[21,237],"and":[22,39,48,57,63,69,77,90,100,149,159,212,246,297,324,342,344],"clinical":[23,64,92,98,309,356],"outcomes.":[24,357],"This":[25,71],"translation":[26],"is":[27],"complicated":[28],"by":[29,328],"the":[30,34,40,75,91,125,143,163,209,265,302,338,347],"delayed":[31],"HbA1c":[32,113],"response,":[33],"progressive":[35],"nature":[36],"of":[37,79,94,124,145,232,287,304,334,340,349],"T2D,":[38,95],"variability":[41,56],"between":[42,60],"patients":[43],"both":[45],"biomarker":[46,273],"trajectories":[47],"complication":[49],"risks.":[50],"Pharmacometric":[51],"models":[52,81],"can":[53,300,319],"characterize":[54,325],"this":[55,221,269,313],"quantify":[58,176],"relationships":[59,306],"treatment,":[61],"biomarkers,":[62,255],"outcomes,":[65],"thereby":[66],"supporting":[67,122],"prediction":[68],"extrapolation.":[70],"thesis":[72,314],"focused":[73],"on":[74,131],"application":[78],"pharmacometric":[80,317],"address":[83],"methodological":[84],"challenges":[85],"across":[86],"course":[93],"using":[96,112,193,235,261],"simulated,":[97],"trial,":[99],"registry":[101,194],"data.":[102,195,310],"Simulation-based":[103],"evaluation":[104],"showed":[105,290],"that,":[106],"under":[107],"appropriate":[108],"model":[109,129,164,187,197],"assumptions,":[110],"trials":[111],"as":[114,259],"an":[115],"endpoint":[116],"may":[117],"shortened":[119],"while":[120],"still":[121],"extrapolation":[123],"long-term":[126,355],"response.":[127],"A":[128],"based":[130],"continuous":[132],"glucose":[133,140,167,335],"monitoring":[134],"data":[135],"was":[136,191],"developed":[137,192],"describe":[139],"profiles":[141],"absence":[144],"recorded":[146],"meal":[147,150],"times":[148],"sizes.":[151],"By":[152],"integrating":[153],"a":[154,170,185],"meal-input":[155],"model,":[156],"glucose-insulin":[157],"dynamics,":[158],"insulin":[160],"glargine":[161],"pharmacokinetics,":[162],"described":[165,198],"population-level":[166],"profiles,":[168,336],"providing":[169],"tool":[171],"prospective":[173],"simulations.":[174],"To":[175,219],"T2D":[177,202,326],"disease":[178],"progression":[179,199,327],"newly":[181],"diagnosed":[182],"adult":[183],"patients,":[184],"multi-state":[186,266],"with":[188,253,354],"competing":[189],"risks":[190,339],"The":[196],"from":[200],"uncomplicated":[201],"macrovascular":[204],"complications,":[205],"diabetic":[206],"kidney":[207],"disease,":[208],"combined":[210],"state,":[211],"death,":[213,343],"quantifying":[214],"how":[215,294,316,346],"complications":[216,341],"accelerate":[217],"mortality.":[218],"complement":[220],"event-based":[222],"analysis,":[223],"routinely":[224],"collected":[225],"were":[227,242,256,275],"integrated":[228,270],"composite":[230,250],"measures":[231],"cardiometabolic":[233],"dysfunction":[234],"item":[236],"theory.":[238],"Two":[239],"underlying":[240],"dimensions":[241],"identified,":[243],"blood":[244],"pressure-related":[245],"metabolic.":[247],"These":[248],"latent":[249],"measures,":[251],"together":[252],"individual":[254],"then":[257],"evaluated":[258],"covariates":[260],"alternative":[262],"representations":[263,274,348],"within":[264],"framework.":[267],"framework,":[271],"time-varying":[272],"generally":[276],"more":[277],"informative":[278,298],"than":[279],"baseline":[280],"values":[281],"transition-specific":[283],"hazards.":[284],"However,":[285],"several":[286],"these":[288],"associations":[289,353],"counterintuitive":[291],"directionality,":[292],"highlighting":[293],"treatment-by-indication":[295],"confounding":[296],"missingness":[299],"complicate":[301],"interpretation":[303,333],"covariate-outcome":[305],"routine":[308],"conclusion,":[312],"demonstrates":[315],"modeling":[318],"support":[320],"informing":[329],"trial":[330],"duration,":[331],"improving":[332],"characterizing":[337],"evaluating":[345],"longitudinal":[350],"influence":[352]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204512780","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-08-28T00:00:00"}
